Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Glomerulonephritis”

775 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 775 results

Early research (Phase 1)Active Not RecruitingNCT06152172
What this trial is testing

CARTIMMUNE: Study of Patients With Autoimmune Diseases Receiving KYV-101

Who this might be right for
Idiopathic Inflammatory MyopathiesDiffuse Cutaneous Systemic SclerosisSLE Nephritis+1 more
David Porter 24
Not applicableStudy completedNCT01838239
What this trial is testing

Development of a Metabolic Assessment Tool for Chronic Kidney Disease

Who this might be right for
Immunoglobulin A NephropathyHealthy Subjects
University of California, Davis 12
Not applicableNot Yet RecruitingNCT06623877
What this trial is testing

Using Renal Elastography Measurements for Evaluation of Glomerulonephritis Patients

Who this might be right for
Evaluation of Biopcy Proven Glomerulonephritis Patients by Renal Shear Wave Elastography
Assiut University 60
Testing effectiveness (Phase 2)Study completedNCT01738035
What this trial is testing

The Effect of Nefecon® in Patients With Primary IgA Nephropathy at Risk of Developing End-stage Renal Disease

Who this might be right for
Primary IgA Nephropathy
Calliditas Therapeutics AB 150
Early research (Phase 1)Study completedNCT00818948
What this trial is testing

Safety Study of AMG 811 in Subjects With Systemic Lupus Erythematosus With and Without Glomerulonephritis

Who this might be right for
NephritisSystemic Lupus Erythematosus
Amgen 56
Testing effectiveness (Phase 2)Looking for participantsNCT06585514
What this trial is testing

Anti-CD19 Chimeric Antigen Receptor T Cells for Refractory Systemic Lupus Erythematosus

Who this might be right for
Systemic Lupus Erythematosus (SLE)Lupus Nephritis (LN)
Beijing GoBroad Hospital 18
Not applicableUnknownNCT06157125
What this trial is testing

Assessment of the Association Between Metabolic Associated Fatty Liver Disease (MFLD) and Biopsy Proved Cases of GN

Who this might be right for
Assessment of Patients With Biopsy Proven Primary Glomerulonephritis Above 18 Years of Age for MFLD Development
Assiut University 100
Large-scale testing (Phase 3)Ended earlyNCT00089804
What this trial is testing

Study of LJP 394 in Lupus Patients With History of Renal Disease

Who this might be right for
Lupus Erythematosus, SystemicLupus Nephritis
La Jolla Pharmaceutical Company 943
Early research (Phase 1)Ended earlyNCT00479622
What this trial is testing

Study of TRU-015 in Subjects With Membranous Nephropathy Secondary to Systemic Lupus Erythematosus

Who this might be right for
Systemic Lupus Erythematosus
Wyeth is now a wholly owned subsidiary of Pfizer 20
Testing effectiveness (Phase 2)Study completedNCT00423098
What this trial is testing

Efficacy and Safety of Enteric-coated Mycophenolate Sodium in Combination With Two Corticosteroid Regimens for the Treatment of Lupus Nephritis Flare

Who this might be right for
Lupus Nephritis
Novartis Pharmaceuticals 81
Not applicableUnknownNCT02435368
What this trial is testing

The Mechanisms and Significances of Synergistic Effects of Mycophenolic Acid and LPS on IL-1β Secretion by Mononuclear

Who this might be right for
Lupus Nephritis
The Third Affiliated Hospital of Southern Medical University 10
Testing effectiveness (Phase 2)UnknownNCT03917797
What this trial is testing

Mesenchymal Stromal Cells (MSC´s) in Renal Lupus

Who this might be right for
Lupus Erythematosus, SystemicLupus Glomerulonephritis
Universidad de los Andes, Chile 39
Testing effectiveness (Phase 2)Ended earlyNCT03448692
What this trial is testing

Evaluate PF-06730512 in Adults With Focal Segmental Glomerulosclerosis (FSGS)

Who this might be right for
Focal Segmental Glomerulosclerosis (FSGS)
Pfizer 47
Early research (Phase 1)Study completedNCT01221181
What this trial is testing

Eculizumab Therapy for Dense Deposit Disease and C3 Nephropathy

Who this might be right for
Dense Deposit DiseaseMembranoproliferative Glomerulonephritis
Columbia University 6
Post-approval studies (Phase 4)UnknownNCT03214731
What this trial is testing

Efficacy and Safety of Artesunate Plus Standard of Care in Active Lupus Nephritis

Who this might be right for
Lupus Nephritis
Sun Yat-sen University 90
Early research (Phase 1)Ended earlyNCT01369628
What this trial is testing

Atacicept in Lupus Nephritis Patients Taking Stable Regimen of Mycophenolate Mofetil

Who this might be right for
Lupus Nephritis
EMD Serono 1
Not applicableUnknownNCT04320667
What this trial is testing

Urinary T Cell Biomarker for Prediction in ANCA Glomerulonephritis

Who this might be right for
Glomerulonephritis Acute
Charite University, Berlin, Germany 79
Large-scale testing (Phase 3)WithdrawnNCT01288664
What this trial is testing

Efficacy and Safety of Tacrolimus Sustained-release Capsules in Induction Phase Treatment in Lupus Nephritis

Who this might be right for
Lupus Nephritis
Sun Yat-sen University
Post-approval studies (Phase 4)Study completedNCT00367562
What this trial is testing

Inhibition of the Renin Angiotensin System Plus Corticosteroids for the Treatment of Proteinuria in IGA Nephropathy

Who this might be right for
IGA Nephropathy
Hospital Britanico 20
Early research (Phase 1)Ended earlyNCT01791686
What this trial is testing

Clinical Trial of CDX-1135 in Pediatric and Adult Patients With Dense Deposit Disease

Who this might be right for
Dense Deposit DiseaseMembranoproliferative Glomerulonephritis Type IIC3 Glomerulonephritis
Celldex Therapeutics 1
Load More Results